miscsubjectsAI governance
Evidence review

GHK Cu for Tirzepatide

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ghk-cu-tirzepatide`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ghk-cu-tirzepatide

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ghk-cu-tirzepatide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ghk-cu-tirzepatide/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ghk-cu-tirzepatide/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ghk-cu-tirzepatide/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

tirzepatide represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether ghk-cu mechanisms address underlying repair deficits.

What is known

ghk-cu is studied for tissue repair mechanisms.

Target condition: tirzepatide. Body system: under investigation.

Logic chain

  1. ghk-cu affects repair signaling.
  2. tirzepatide involves pathological tissue change.
  3. If ghk-cu reaches the affected tissue, it may shift the repair/breakdown balance.
  4. This chain is tested in animal or lab models only.

Parent peptide claims relevant here

  • Plasma GHK levels measure approximately 200 ng/mL at age 20 and decline to approximately 80 ng/mL by age 60.
  • In human dermal fibroblast cultures, GHK-Cu at nanomolar concentrations increases synthesis of collagen types I, III, and IV as well as elastin and glycosaminoglycans.
  • Placebo-controlled topical application studies in women around age 50 reported improved skin quality parameters and increased collagen deposition in skin biopsies.
  • A registered Phase 2 randomized double-blind trial (NCT07437586) is evaluating topical GHK-Cu gel versus vehicle for acute skin wound re-epithelialization in healthy adults.
  • 2018 review on GHK-Cu regenerative actions based on gene data, covering wound healing, skin regeneration, anti-inflammatory effects.

Evidence tier

Preclinical — animal and in vitro studies only. No published human trials for this specific combination.

What we do not know

  • Whether ghk-cu reaches tirzepatide tissue at functional concentrations
  • Optimal dosing, route, and duration for this target
  • Interaction with standard-of-care treatments for tirzepatide
  • Long-term safety profile in this population

Safety note

All peptide use for tirzepatide is research-context only. Not medical advice. Consult a physician before any experimental compound.

Explore this article's relationships

Skin / collagen · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Ask this article · 2 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

For my medical situation, what can you answer from your catalogue about GHK Cu for Tirzepatide — and what would you need me to tell you first?
ask ghk-cu-tirzepatide condition gaps · paste includes §SELF
What good and bad outcomes are documented for GHK Cu for Tirzepatide (studies vs anecdotes)?
ask ghk-cu-tirzepatide good bad experiences · paste includes §SELF
ghk-cu-tirzepatide · posted 2026-06-29 · updated 2026-07-17
Ledger API & provenance
Provenance · 1 model pass · 0 tokens · $0 · 1 model
chain head 8a4d2772bba0c91f
voxel_divide owner · 2026-07-17 02:39 · 0 tok · 8a4d2772bba0
verify chain →
Live ledger · 2 payloads · 0 turns
recent activity · inspect
JCI_CLASSIFY jci · HTTP 200 · 2026-07-19 07:09
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 07:09
view full ledger & cards →
REST + ledger
read GET /api/articles/ghk-cu-tirzepatide · GET /api/articles/ghk-cu-tirzepatide?format=post (the editable body)
create/replace POST /api/articles/ghk-cu-tirzepatide · PUT /api/articles/ghk-cu-tirzepatide (replace, keeps revision) · PATCH /api/articles/ghk-cu-tirzepatide (merge)
delete DELETE /api/articles/ghk-cu-tirzepatide
writes need header x-terminal-key
LLM bundle GET /api/articles/ghk-cu-tirzepatide/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim ghk-cu-tirzepatide|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…